Cargando…
1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506452/ http://dx.doi.org/10.1016/j.annonc.2020.08.1766 |
| _version_ | 1783585021500588032 |
|---|---|
| author | Nichetti, F. Bini, M. Dotti, K.F. Ottini, A. Ambrosini, M. Rametta, A. Leporati, R. Ferrari, L. De Braud, F.G.M. |
| author_facet | Nichetti, F. Bini, M. Dotti, K.F. Ottini, A. Ambrosini, M. Rametta, A. Leporati, R. Ferrari, L. De Braud, F.G.M. |
| author_sort | Nichetti, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75064522020-09-23 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study Nichetti, F. Bini, M. Dotti, K.F. Ottini, A. Ambrosini, M. Rametta, A. Leporati, R. Ferrari, L. De Braud, F.G.M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506452/ http://dx.doi.org/10.1016/j.annonc.2020.08.1766 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Nichetti, F. Bini, M. Dotti, K.F. Ottini, A. Ambrosini, M. Rametta, A. Leporati, R. Ferrari, L. De Braud, F.G.M. 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study |
| title | 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study |
| title_full | 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study |
| title_fullStr | 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study |
| title_full_unstemmed | 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study |
| title_short | 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study |
| title_sort | 1702p covid-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the national cancer institute of milan: the covint study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506452/ http://dx.doi.org/10.1016/j.annonc.2020.08.1766 |
| work_keys_str_mv | AT nichettif 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT binim 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT dottikf 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT ottinia 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT ambrosinim 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT ramettaa 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT leporatir 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT ferraril 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy AT debraudfgm 1702pcovid19riskforpatientsundergoinganticancertreatmentattheoutpatientclinicofthenationalcancerinstituteofmilanthecovintstudy |